Complement C1q Reduces Early Atherosclerosis in Low-density Lipoprotein Receptor-deficient Mice

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2007 Jan 4

PMID 17200212

Citations 82

Authors

Vinay K Bhatia

Sheng Yun

Viola Leung

David C Grimsditch

G Martin Benson

Marina B Botto

Joseph J Boyle

Dorian O Haskard

Affiliations

Soon will be listed here.

Abstract

We explored the role of the classic complement pathway in atherogenesis by intercrossing C1q-deficient mice (C1qa-/-) with low-density lipoprotein receptor knockout mice (Ldlr-/-). Mice were fed a normal rodent diet until 22 weeks of age. Aortic root lesions were threefold larger in C1qa-/-/Ldlr-/- mice compared with Ldlr-/- mice (3.72 +/- 1.0% aortic root versus 1.1 +/- 0.4%; mean +/- SEM, P < 0.001). Furthermore, the cellular composition of lesions in C1qa-/-/Ldlr-/- was more complex, with an increase in vascular smooth muscle cells. The greater aortic root lesion size in C1qa-/-/Ldlr-/- mice occurred despite a significant reduction in C5b-9 deposition per lesion unit area, suggesting the critical importance of proximal pathway activity. Apoptotic cells were readily detectable by cleaved caspase-3 staining, terminal deoxynucleotidyl transferase dUTP nick-end labeling assay, and electron microscopy in C1qa-/-/Ldlr-/-, whereas apoptotic cells were not detected in Ldlr-/- mice. This is the first direct demonstration of a role for the classic complement pathway in atherogenesis. The greater lesion size in C1qa-/-/Ldlr-/- mice is consistent with the emerging homeostatic role for C1q in the disposal of dying cells. This study suggests the importance of effective apoptotic cell removal for containing the size and complexity of early lesions in atherosclerosis.

Citing Articles

The complement system in lipid-mediated pathologies.

Alic L, Dendinovic K, Papac-Milicevic N Front Immunol. 2024; 15:1511886.

PMID: 39635529 PMC: 11614835. DOI: 10.3389/fimmu.2024.1511886.

Common ground on immune infiltration landscape and diagnostic biomarkers in diabetes-complicated atherosclerosis: an integrated bioinformatics analysis.

Qi Y, Zhang Y, Guan S, Liu L, Wang H, Chen Y Front Endocrinol (Lausanne). 2024; 15:1381229.

PMID: 39145311 PMC: 11323117. DOI: 10.3389/fendo.2024.1381229.

Endothelial Immunosuppression in Atherosclerosis : Translational Control by Elavl1/HuR.

Nicholas S, Helming S, Menoret A, Pathoulas C, Xu M, Hensel J bioRxiv. 2024; .

PMID: 39131295 PMC: 11312609. DOI: 10.1101/2024.08.02.605922.

Correlation between Complement C1q A Chain () and Macrophages in the Progression of Carotid Atherosclerosis.

Dong G, Yu X, Zhao M, Lin S, Meng Q Iran J Public Health. 2024; 53(7):1517-1527.

PMID: 39086409 PMC: 11287601. DOI: 10.18502/ijph.v53i7.16046.

Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanisms.

Sheng Y, Hu W, Chen S, Zhu X Front Immunol. 2024; 15:1275203.

PMID: 38779685 PMC: 11109379. DOI: 10.3389/fimmu.2024.1275203.

References

Tsimikas S, Palinski W, Witztum J . Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2001; 21(1):95-100. DOI: 10.1161/01.atv.21.1.95. View

Rus H, Niculescu F, Vlaicu R . Co-localization of terminal C5b-9 complement complexes and macrophages in human atherosclerotic arterial walls. Immunol Lett. 1988; 19(1):27-32. DOI: 10.1016/0165-2478(88)90115-0. View

Walport M . Complement. First of two parts. N Engl J Med. 2001; 344(14):1058-66. DOI: 10.1056/NEJM200104053441406. View

Walport M . Complement. Second of two parts. N Engl J Med. 2001; 344(15):1140-4. DOI: 10.1056/NEJM200104123441506. View

Patel S, Thelander E, Hernandez M, Montenegro J, Hassing H, Burton C . ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5. Biochem Biophys Res Commun. 2001; 286(1):164-70. DOI: 10.1006/bbrc.2001.5276. View

Fishelson Z, Attali G, Mevorach D . Complement and apoptosis. Mol Immunol. 2001; 38(2-3):207-19. DOI: 10.1016/s0161-5890(01)00055-4. View

Ogden C, deCathelineau A, Hoffmann P, Bratton D, Ghebrehiwet B, Fadok V . C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001; 194(6):781-95. PMC: 2195958. DOI: 10.1084/jem.194.6.781. View

Niculescu F, Rus H . Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells. Immunol Res. 2001; 24(2):191-9. DOI: 10.1385/ir:24:2:191. View

Ares M, Yan Z, Bu D, Fredrikson G, Branen L, Nilsson A . Increased rate of apoptosis in intimal arterial smooth muscle cells through endogenous activation of TNF receptors. Arterioscler Thromb Vasc Biol. 2001; 21(12):1909-14. DOI: 10.1161/hq1201.100222. View

10.

Mitchell D, Pickering M, Warren J, Fossati-Jimack L, Cortes-Hernandez J, Cook H . C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol. 2002; 168(5):2538-43. DOI: 10.4049/jimmunol.168.5.2538. View

11.

Buono C, Come C, Witztum J, Maguire G, Connelly P, Carroll M . Influence of C3 deficiency on atherosclerosis. Circulation. 2002; 105(25):3025-31. DOI: 10.1161/01.cir.0000019584.04929.83. View

12.

Nauta A, Trouw L, Daha M, Tijsma O, Nieuwland R, Schwaeble W . Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol. 2002; 32(6):1726-36. DOI: 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R. View

13.

Tabas I . Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest. 2002; 110(7):905-11. PMC: 151158. DOI: 10.1172/JCI16452. View

14.

Boyle J, Weissberg P, Bennett M . Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions. Arterioscler Thromb Vasc Biol. 2002; 22(10):1624-30. DOI: 10.1161/01.atv.0000033517.48444.1a. View

15.

Duan W, Garner D, Williams S, Funckes-Shippy C, Spath I, Blomme E . Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol. 2003; 199(2):221-8. DOI: 10.1002/path.1289. View

16.

Oksjoki R, Jarva H, Kovanen P, Laine P, Meri S, Pentikainen M . Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation. Arterioscler Thromb Vasc Biol. 2003; 23(4):630-6. DOI: 10.1161/01.ATV.0000057808.91263.A4. View

17.

Loidl A, Sevcsik E, Riesenhuber G, Deigner H, Hermetter A . Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. J Biol Chem. 2003; 278(35):32921-8. DOI: 10.1074/jbc.M306088200. View

18.

Carpenter K, Challis I, Arends M . Mildly oxidised LDL induces more macrophage death than moderately oxidised LDL: roles of peroxidation, lipoprotein-associated phospholipase A2 and PPARgamma. FEBS Lett. 2003; 553(1-2):145-50. DOI: 10.1016/s0014-5793(03)01007-x. View

19.

Robertson A, Rudling M, Zhou X, Gorelik L, Flavell R, Hansson G . Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest. 2003; 112(9):1342-50. PMC: 228445. DOI: 10.1172/JCI18607. View

20.

Kadl A, Bochkov V, Huber J, Leitinger N . Apoptotic cells as sources for biologically active oxidized phospholipids. Antioxid Redox Signal. 2004; 6(2):311-20. DOI: 10.1089/152308604322899378. View